Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,348,068 papers from all fields of science
Search
Sign In
Create Free Account
gadoversetamide
Known as:
(N,N-Bis(2-((carboxymethyl)(((2-methoxyethyl)carbamoyl)methyl)amino)ethyl)glycinato(3-))gadolinium
, Gadoversetamida
, gadoversetamide [Chemical/Ingredient]
Expand
A paramagnetic extracellular magnetic resonance imaging (MRI) contrast agent that facilitates visualization of abnormal vascularity. When placed in a…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (2)
Contrast Media
Organometallic Compounds
GADOVERSETAMIDE 0.5 mmol in 1 mL INTRAVENOUS INJECTION, SOLUTION [OPTIMARK]
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Case 163: solitary neurocysticercosis.
G. Yeaney
,
Balasubramanya S Kolar
,
H. Silberstein
,
Henry Z. Wang
Radiology
2010
Corpus ID: 34387592
While a parenchymal cysticercal lesion in the brain may cause a diagnostic dilemma, radiologic features correlate with pathologic…
Expand
Highly Cited
2010
Highly Cited
2010
Effect of different classes of gadolinium-based contrast agents on control and nephrogenic systemic fibrosis-derived fibroblast proliferation.
M. Edward
,
Jean A. Quinn
,
A. David Burden
,
Ben B. Newton
,
Alan G. Jardine
Radiology
2010
Corpus ID: 1363987
PURPOSE To determine the ability of different types of gadolinium-based contrast agents (GBCAs) to stimulate fibroblast…
Expand
2008
2008
Safety of gadoversetamide in patients with acute and chronic myocardial infarction
S. Huber
,
R. Muthupillai
,
+17 authors
S. Flamm
Journal of Magnetic Resonance Imaging
2008
Corpus ID: 354430
To assess the safety data from two large, multicenter, phase 2 trials on the use of gadoversetamide (OptiMARK, Tyco Healthcare…
Expand
2007
2007
Gain in signal-to-noise for first-pass contrast-enhanced abdominal MR angiography at 3 Tesla over standard 1.5 Tesla: prediction with a computer model.
E. Merkle
,
B. Dale
,
D. Barboriak
Academic Radiology
2007
Corpus ID: 40703856
2004
2004
Measurement of serum calcium concentration after administration of gadoversetamide in dogs.
J. Wible
,
M. Hynes
Radiology
2004
Corpus ID: 44913518
PURPOSE To measure serum calcium concentration with three different analytic methods after administration of gadoversetamide and…
Expand
2004
2004
Safety assessment of gadoversetamide (OptiMARK®) administered by power injector
N. Abdou
,
A. Napoli
,
M. Hynes
,
J. C. Allen
,
J. Wible
Journal of Magnetic Resonance Imaging
2004
Corpus ID: 35011277
To evaluate the safety of OptiMARK® (gadoversetamide injection) administered via power injector.
2004
2004
Spurious hypocalcemia after Omniscan- or OptiMARK-enhanced magnetic resonance imaging: an algorithm for minimizing a false-positive laboratory value.
J. Emerson
,
G. Kost
Archives of Pathology & Laboratory Medicine
2004
Corpus ID: 40435053
Contrast-enhanced magnetic resonance imaging has become a routine diagnostic imaging procedure. Reports in the literature…
Expand
2001
2001
Cardiovascular Effects Caused by Rapid Administration of Gadoversetamide Injection in Anesthetized Dogs
J. Wible
,
K. Galen
,
J. Wojdyla
Investigative Radiology
2001
Corpus ID: 21102901
Wible JH, Galen KP, Wojdyla J. Cardiovascular effects caused by rapid administration of gadoversetamide injection in anesthetized…
Expand
1999
1999
A multicenter, randomized, double‐blind study to evaluate the safety, tolerability, and efficacy of OptiMARK (gadoversetamide injection) compared with Magnevist (gadopentetate dimeglumine) in…
D. Rubin
,
T. Desser
,
+10 authors
J. A. Pierro
1999
Corpus ID: 196412169
The purpose of this study was to evaluate the safety and efficacy of OptiMARK (gadoversetamide injection) compared with Magnevist…
Expand
1999
1999
A multicenter, randomized, double-blind study to evaluate the safety, tolerability, and efficacy of OptiMARK (gadoversetamide injection) compared with Magnevist (gadopentetate dimeglumine) in…
D. Rubin
,
T. Desser
,
+10 authors
J. A. Pierro
Journal of Magnetic Resonance Imaging
1999
Corpus ID: 33911149
The purpose of this study was to evaluate the safety and efficacy of OptiMARK (gadoversetamide injection) compared with Magnevist…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE